Serine Peptidase HTRA3 Is Closely Associated with Human Placental Development and Is Elevated in Pregnancy Serum1

Abstract HTRA3 is a newly identified serine peptidase of the mammalian HTRA (high-temperature requirement factor A) family, that is upregulated dramatically during mouse placental development. The current study determined whether HTRA3 was involved in human placentation. During the menstrual cycle, HTRA3 was expressed primarily in the endometrial glands, being significantly upregulated toward the mid- to late secretory phases; prominent expression in the stroma detected only in the decidual cells in the late secretory phase. Thus, overall endometrial HTRA3 expression was highest in the late secretory phase, when the endometrium is prepared for maternal-trophoblast interaction. During the first trimester of pregnancy, both glandular and decidual HTRA3 expression increased further with the decidual upregulation being highly significant. The strong link between HTRA3 expression and endometrial stromal cell decidualization was further established in an in vitro model using primary endometrial stromal cells. HTRA3 was also expressed by certain trophoblast subtypes in the first-trimester placenta: strongly in the villous syncytiotrophoblast, trophoblast shell, and endovascular trophoblast and weakly in the distal portion of the trophoblast cell columns but not in villous cytotrophoblast, the proximal region of the cell columns, or interstitial trophoblast. Upregulation of HTRA3 expression in association with placental development was revealed by a significant elevation of this protein in the maternal serum during the first trimester. We thus propose that HTRA3 is a previously unrecognized factor closely associated with and potentially important for human placentation. This study established crucial groundwork for future investigations toward establishing the physiological roles of HTRA3 in human placentation.

[1]  Y. Li,et al.  HtrA3, a serine protease possessing an IGF-binding domain, is selectively expressed at the maternal-fetal interface during placentation in the mouse. , 2006, Placenta.

[2]  M. Kawaichi,et al.  Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. , 2005, Bone.

[3]  S. Robson,et al.  Inhibition of Trophoblast Cell Invasion by TGFB1, 2, and 3 Is Associated with a Decrease in Active Proteases1 , 2005, Biology of reproduction.

[4]  J. Pollheimer,et al.  Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. , 2005, Placenta.

[5]  D. Clemmons,et al.  Expression and characterization of a serine protease that preferentially cleaves insulin‐like growth factor binding protein‐5 , 2005, Journal of cellular biochemistry.

[6]  L. Salamonsen,et al.  Requirement for proprotein convertase 5/6 during decidualization of human endometrial stromal cells in vitro. , 2005, The Journal of clinical endocrinology and metabolism.

[7]  M. Westwood,et al.  Matrix Metalloprotease-3 and -9 Proteolyze Insulin-Like Growth Factor-Binding Protein-11 , 2004, Biology of reproduction.

[8]  M. Kawaichi,et al.  Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF‐β signaling , 2004, Development, growth & differentiation.

[9]  C. Roberts,et al.  The insulin-like growth factor system in mammalian pregnancy--a workshop report. , 2004, Placenta.

[10]  M. Kawaichi,et al.  HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins , 2004, Development.

[11]  Y. Li,et al.  A novel serine protease of the mammalian HtrA family is up-regulated in mouse uterus coinciding with placentation. , 2003, Molecular human reproduction.

[12]  L. Salamonsen,et al.  Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. , 2003, The Biochemical journal.

[13]  L. Giudice,et al.  Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. , 2003, Placenta.

[14]  L. Salamonsen,et al.  Specific and Transient Up-Regulation of Proprotein Convertase 6 at the Site of Embryo Implantation and Identification of a Unique Transcript in Mouse Uterus During Early Pregnancy1 , 2003, Biology of reproduction.

[15]  L. Giudice,et al.  Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane. , 2002, The Journal of clinical endocrinology and metabolism.

[16]  C. Southan,et al.  The HtrA family of proteases: implications for protein composition and cell fate. , 2002, Molecular cell.

[17]  Guoxiong Xu,et al.  Control of Proliferation, Migration, and Invasiveness of Human Extravillous Trophoblast by Decorin, a Decidual Product1 , 2002, Biology of reproduction.

[18]  C. C. Pillai,et al.  Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. , 2002, The Journal of clinical investigation.

[19]  W. Reik,et al.  Placental-specific IGF-II is a major modulator of placental and fetal growth , 2002, Nature.

[20]  P. Lala,et al.  Regulation of human trophoblast migration and invasiveness. , 2002, Canadian journal of physiology and pharmacology.

[21]  M. Westwood,et al.  Regulation of IGF bioavailability in pregnancy. , 2001, Molecular human reproduction.

[22]  L. Sunde,et al.  Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. , 2000, Molecular human reproduction.

[23]  J. Aplin,et al.  Maternal influences on placental development. , 2000, Seminars in cell & developmental biology.

[24]  L. Giudice,et al.  Role of the IGF system in trophoblast invasion and pre-eclampsia. , 1999, Human reproduction.

[25]  H. Tournaye,et al.  No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen-thawed epididymal spermatozoa. , 1999, Human reproduction.

[26]  V. Han,et al.  Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. , 1998, Experimental cell research.

[27]  D. Clemmons Role of insulin-like growth factor binding proteins in controlling IGF actions , 1998, Molecular and Cellular Endocrinology.

[28]  J. Godkin,et al.  Transforming growth factor beta and the endometrium. , 1998, Reviews of reproduction.

[29]  S. Dey,et al.  Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice , 1997, Cell.

[30]  S. Potter,et al.  Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. , 1997, Biology of reproduction.

[31]  V. Han,et al.  The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. , 1996, The Journal of clinical endocrinology and metabolism.

[32]  G. Hamilton,et al.  Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. , 1996, Placenta.

[33]  J. S. Hunt,et al.  Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. , 1995, Placenta.

[34]  J. Irving,et al.  Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. , 1995, Experimental cell research.

[35]  Y. W. Loke,et al.  Human implantation : cell biology and immunology , 1995 .

[36]  S. Handwerger,et al.  Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding. , 1993, Endocrinology.

[37]  R. M. Wynn Ultrastructural development of the human decidua. , 1974, American journal of obstetrics and gynecology.